![]()
|
|
||||||||
J. Biol. Chem., Vol. 278, Issue 49, 49230-49238, December 5, 2003
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
-Arrestins*

¶
||
From the
University of Alabama at Birmingham, Comprehensive Cancer Center, Birmingham, Alabama 35294-3300 and ||Molecular Pharmacology Group, Division of Biochemistry and Molecular Biology, Wolfson Building, Institute of Biomedical and Life Sciences, University of Glasgow, Glasgow G12 8QQ, Scotland, United Kingdom
Isoproterenol challenge of Hek-B2 cells causes a transient recruitment of the endogenous PDE4D isoforms found in these cells, namely PDE4D3 and PDE4D5, to the membrane fraction. PDE4D5 provides around 80% of the total PDE4D protein so recruited, although it only comprises about 40% of the total PDE4D protein in Hek-B2 cells. PDE4D5 provides about 80% of the total PDE4D protein found associated with
-arrestins immunopurified from Hek-B2, COS1, and A549 cells as well as cardiac myocytes, whereas its overall level in these cells is between 15 and 50% of the total PDE4D protein. Truncation analyses indicate that two sites in PDE4D5 are involved in mediating its interaction with
-arrestins, one associated with the common PDE4 catalytic region and the other located within its unique amino-terminal region. Truncation analyses indicate that two sites in
-arrestin 2 are involved in mediating its interaction with PDE4D5, one associated with its extreme amino-terminal region and the other located within the carboxyl-terminal domain of the protein. We suggest that the unique amino-terminal region of PDE4D5 allows it to preferentially interact with
-arrestins. This specificity appears likely to account for the preferential recruitment of PDE4D5, compared with PDE4D3, to membranes of Hek-B2 cells and cardiac myocytes upon challenge with isoproterenol.
Received for publication, April 10, 2003 , and in revised form, September 11, 2003.
* This work was supported in part by National Institutes of Health Grant R01-GM58553 (to G. B. B.), by Medical Research Council (UK) Grant G8604010 (to M. D. H.), and by European Union Grants QLG2-CT-2001-02278 and QLK3-CT-2002-02149 (to M. D. H.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Recipient of Biomedical Research Collaborative Travel Grant 061247/Z/00/Z from the Wellcome Trust, UK.
¶ To whom correspondence should be addressed: University of Alabama at Birmingham, Comprehensive Cancer Center, WTI 520, 1530 3rd Ave. S., Birmingham, AL 35294-3300. Tel.: 205-975-9375; Fax: 205-975-6911; E-mail: Graeme.Bolger{at}ccc.uab.edu.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
C. K. Billington, I. R. Le Jeune, K. W. Young, and I. P. Hall A Major Functional Role for Phosphodiesterase 4D5 in Human Airway Smooth Muscle Cells Am. J. Respir. Cell Mol. Biol., January 1, 2008; 38(1): 1 - 7. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Willoughby, G. S. Baillie, M. J. Lynch, A. Ciruela, M. D. Houslay, and D. M. F. Cooper Dynamic Regulation, Desensitization, and Cross-talk in Discrete Subcellular Microdomains during beta2-Adrenoceptor and Prostanoid Receptor cAMP Signaling J. Biol. Chem., November 23, 2007; 282(47): 34235 - 34249. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Levallet, J. Levallet, H. Bouraima-Lelong, and P.-J. Bonnamy Expression of the cAMP-Phosphodiesterase PDE4D Isoforms and Age-Related Changes in Follicle-Stimulating Hormone-Stimulated PDE4 Activities in Immature Rat Sertoli Cells Biol Reprod, May 1, 2007; 76(5): 794 - 803. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. D. Houslay, G. S. Baillie, and D. H. Maurice cAMP-Specific Phosphodiesterase-4 Enzymes in the Cardiovascular System: A Molecular Toolbox for Generating Compartmentalized cAMP Signaling Circ. Res., April 13, 2007; 100(7): 950 - 966. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Fischmeister, L. R.V. Castro, A. Abi-Gerges, F. Rochais, J. Jurevicius, J. Leroy, and G. Vandecasteele Compartmentation of Cyclic Nucleotide Signaling in the Heart: The Role of Cyclic Nucleotide Phosphodiesterases Circ. Res., October 13, 2006; 99(8): 816 - 828. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Huston, I. Gall, T. M. Houslay, and M. D. Houslay Helix-1 of the cAMP-specific phosphodiesterase PDE4A1 regulates its phospholipase-D-dependent redistribution in response to release of Ca2+ J. Cell Sci., September 15, 2006; 119(18): 3799 - 3810. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Giembycz and R. Newton Beyond the dogma: novel {beta}2-adrenoceptor signalling in the airways. Eur. Respir. J., June 1, 2006; 27(6): 1286 - 1306. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Rochais, A. Abi-Gerges, K. Horner, F. Lefebvre, D. M.F. Cooper, M. Conti, R. Fischmeister, and G. Vandecasteele A Specific Pattern of Phosphodiesterases Controls the cAMP Signals Generated by Different Gs-Coupled Receptors in Adult Rat Ventricular Myocytes Circ. Res., April 28, 2006; 98(8): 1081 - 1088. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Lynch, G. S. Baillie, A. Mohamed, X. Li, C. Maisonneuve, E. Klussmann, G. van Heeke, and M. D. Houslay RNA Silencing Identifies PDE4D5 as the Functionally Relevant cAMP Phosphodiesterase Interacting with {beta}Arrestin to Control the Protein Kinase A/AKAP79-mediated Switching of the {beta}2-Adrenergic Receptor to Activation of ERK in HEK293B2 Cells J. Biol. Chem., September 30, 2005; 280(39): 33178 - 33189. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Park, J.-A Lee, C. Lee, M.-J. Kim, D.-J. Chang, H. Kim, S.-H. Lee, Y.-S. Lee, and B.-K. Kaang An Aplysia Type 4 Phosphodiesterase Homolog Localizes at the Presynaptic Terminals of Aplysia Neuron and Regulates Synaptic Facilitation J. Neurosci., September 28, 2005; 25(39): 9037 - 9045. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Wallace, L. A. Johnston, E. Huston, D. MacMaster, T. M. Houslay, Y.-F. Cheung, L. Campbell, J. E. Millen, R. A. Smith, I. Gall, et al. Identification and Characterization of PDE4A11, a Novel, Widely Expressed Long Isoform Encoded by the Human PDE4A cAMP Phosphodiesterase Gene Mol. Pharmacol., June 1, 2005; 67(6): 1920 - 1934. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Bradaia, F. Berton, S. Ferrari, and C. Luscher {beta}-Arrestin2, interacting with phosphodiesterase 4, regulates synaptic release probability and presynaptic inhibition by opioids PNAS, February 22, 2005; 102(8): 3034 - 3039. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Rochais, G. Vandecasteele, F. Lefebvre, C. Lugnier, H. Lum, J.-L. Mazet, D. M. F. Cooper, and R. Fischmeister Negative Feedback Exerted by cAMP-dependent Protein Kinase and cAMP Phosphodiesterase on Subsarcolemmal cAMP Signals in Intact Cardiac Myocytes: AN IN VIVO STUDY USING ADENOVIRUS-MEDIATED EXPRESSION OF CNG CHANNELS J. Biol. Chem., December 10, 2004; 279(50): 52095 - 52105. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |